(Q51553752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Effects of oral pinaverium bromide on colonic response to food in irritable bowel syndrome patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

main subject

irritable bowel syndrome

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Faye A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Devroede G

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Arsac M

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

Biomedicine and Pharmacotherapy

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

381-387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

Verapamil hydrochloride: pharmacological properties and role in cardiovascular therapeutics

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Nifedipine and verapamil inhibit the sigmoid colon myoelectric response to eating in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Abnormal rectosigmoid myoelectric response to eating in patients with severe idiopathic constipation (slow-transit type)

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Effects of pinaverium bromide and verapamil on the motility of the rat isolated colon

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Effect of eating on colonic motility and transit in patients with functional diarrhea. Simultaneous scintigraphic and manometric evaluations.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

What is the meaning of colorectal transit time measurement?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Effect of pinaverium bromide on jejunal motility and colonic transit time in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Action of pinaverium bromide, a calcium-antagonist, on gastrointestinal motility disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Effect of pinaverium bromide on electrical and mechanical activity of smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Functional bowel disorders. A multicenter comparison of health status and development of illness severity index

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Interaction of pinaverium (a quaternary ammonium compound) with 1,4‐dihydropyridine binding sites in rat ileum smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Involvement of a CCK-dependent capsaicin-sensitive afferent pathway in the inhibitory effect of pinaverium bromide on the colonic motor response to eating in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Inhibition of the colonic motor response to eating by pinaverium bromide in irritable bowel syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Zamifenacin (UK-76, 654) a potent gut M3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Towards positive diagnosis of the irritable bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Verapamil effective in irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Right and left colonic transit after eating assessed by a dual isotopic technique in healthy humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

The effect of meal composition on the gastrocolonic response: implications for drug delivery to the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Reduction of colonic motility by intravenous nicardipine in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Cephalic phase of colonic pressure response to food

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Physiology and pathophysiology of colonic motor activity (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Eating attitudes and the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Proceedings: Comparative effects of codeine and senna on the motor activity of the left colon

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

Participation of gastric mechanoreceptors and intestinal chemoreceptors in the gastrocolonic response

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2980005-6

7 January 2021

10.1016/S0753-3322(01)80005-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10989977%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference